|
Main characteristics that served in selection of groups of patients under study |
||||||
| MEN |
WOMEN |
|||||
|
|
||||||
| Controls N = 10 Mean ± SD |
Hyperlipemic patients N = 20 Mean ± SD |
p |
Controls N = 20 Mean ± SD |
Hyperlipemic patients N = 20 Mean ± SD |
p |
|
|
|
||||||
| Age (years) |
60.3 ± 11.0 |
58.6 ± 10.4 |
0.69 |
56.9 ± 13.0 |
62.0 ± 7.36 |
0.15 |
| Cholesterol (mmol/l) |
5.07 ± 1.06 |
6.62 ± 0.82 |
0.0001 |
5.15 ± 0.70 |
6.92 ± 1.01 |
0.0001 |
| Triglycerides (mmol/l) |
1.11 ± 0.44 |
3.52 ± 1.38 |
0.0001 |
1.42 ± 0.47 * |
2.72 ± 0.92* |
0.0001 KS |
| HDL-chol. (mmol/l) |
1.43 ± 0.39 |
0.96 ± 0.24 |
0.0003 |
1.50 ± 0.21 |
1.21 ± 0.21*** |
0.0001 |
| LDL-chol. (mmol/l) |
3.08 ± 0.83 |
4.38 ± 1.06 |
0.0047 |
3.21 ± 0.71 |
4.74 ± 1.02 |
0.0001 |
|
Statistical significance between control and hyperlipemic groups was tested using the unpaired Student's T-test in the case of normal distribution of compared data sets, and using Kolmogorov-Smirnov's test when at least in one of the data sets compared the normal distribution was excluded (marked with KS). The significant p values are denoted by thick underlined numbers. With asterisks statistically significant differences between controls and hypelipemic patients of different gender are denoted (*, **, *** = p < 0,05, 0,01 and 0,001, respectively). | ||||||
Lichnovská et al. Cardiovascular Diabetology 2002 1:4 doi:10.1186/1475-2840-1-4 |
||||||